Cargando…
Exogenous surfactant therapy for acute respiratory distress in infancy
Autores principales: | Moreno, M., López-Herce, J., Merello, C., Alcaraz, A., Carrillo, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095323/ https://www.ncbi.nlm.nih.gov/pubmed/8857444 http://dx.doi.org/10.1007/BF01728337 |
Ejemplares similares
-
Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment?
por: Koumbourlis, Anastassios C., et al.
Publicado: (2020) -
Exogenous Surfactant Therapy in Acute Lung Injury/Acute Respiratory Distress Syndrome: The Need for a Revised Paradigm Approach
por: Dushianthan, Ahilanandan, et al.
Publicado: (2012) -
Exogenous pulmonary surfactant for acute respiratory distress syndrome in adults: A systematic review and meta-analysis
por: ZHANG, LI-NA, et al.
Publicado: (2013) -
Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis
por: Davidson, Warren J, et al.
Publicado: (2006) -
Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome - where do we go from here?
por: Dushianthan, Ahilanandan, et al.
Publicado: (2012)